Mechanotransduction and Chemoresistance: The Impact of High Viscosity on P-gp Expression in Cancer Cells

Study Background and Research Question

Chemoresistance remains a formidable challenge in cancer therapy, undermining the efficacy of even the most potent chemotherapeutic regimens. While genetic, epigenetic, and biochemical factors have long been studied as contributors to drug resistance, recent research has begun to illuminate the critical role of the tumor microenvironment’s physical and mechanical properties. Among these, the viscosity of the tumor interstitial fluid is markedly higher than that of healthy tissue, yet its direct impact on drug resistance mechanisms has been poorly understood. The reference study (Zhou et al., 2026) directly addresses this gap, asking whether and how high extracellular fluid viscosity modulates chemoresistance in cancer cells, specifically through alterations in P-glycoprotein (P-gp, also known as ABCB1) expression.

Key Innovation from the Reference Study

The central innovation of this study lies in its demonstration that the mechanical cue of elevated extracellular viscosity can independently induce chemoresistance in cancer cells by upregulating P-gp. This is achieved through a defined mechanotransduction pathway linking cytoskeletal changes, membrane tension, and the activation of transcriptional programs that drive P-gp expression. By situating viscosity as a primary variable in the regulation of drug efflux transporters, the work adds a new dimension to our understanding of transporter-mediated drug disposition and cancer chemoresistance studies.

Methods and Experimental Design Insights

The authors employed a combination of biophysical measurements, molecular assays, and functional drug resistance tests. Cancer cells were cultured in media adjusted to normal (~0.7 cP) or tumor-mimicking high viscosity (~8 cP) levels. Atomic force microscopy and fluorescence lifetime measurements were used to quantify changes in cell membrane tension following exposure to high-viscosity environments. Cytoskeletal organization was assessed by staining for F-actin and vinculin, while water influx dynamics were probed via Na⁺/H⁺ exchanger 1 (NHE1) and aquaporin 1 (AQP1) activity. The activation state of mechanosensitive channels, specifically TRPV4, was evaluated alongside intracellular Ca²⁺ imaging. Downstream, the localization and activity of Yes-associated protein (YAP)—a key mechanosensitive transcriptional regulator—were monitored, and the expression of its target genes (CTGF, CYR61) was quantified. Finally, P-gp mRNA and protein levels were measured, and functional chemoresistance was assessed using doxorubicin efflux and cytotoxicity assays.

Protocol Parameters

• High viscosity media preparation: Adjust culture media to ~8 cP using inert polymers to model tumor-like conditions.
• Membrane tension measurement: Utilize atomic force microscopy and fluorescence lifetime imaging to assess biophysical changes post-exposure.
• Cytoskeletal assessment: Employ phalloidin and vinculin immunostaining to quantify F-actin/vinculin density.
• Mechanosensitive channel inhibition: Use TRPV4 antagonists as controls to delineate channel-specific effects.
• Transcriptional inhibition: Apply YAP inhibitors to confirm pathway dependence of P-gp upregulation.
• Drug efflux functional assays: Measure intracellular doxorubicin fluorescence and cell viability after chemotherapeutic challenge.

Core Findings and Why They Matter

The study demonstrates that high extracellular fluid viscosity triggers a cascade of mechanical and biochemical events culminating in increased P-gp expression and enhanced chemoresistance:

• Mechanical stimulation: Elevated viscosity enhances F-actin/vinculin cytoskeletal density and promotes NHE1/AQP1-dependent water influx, leading to increased membrane tension.
• Mechanosensitive channel activation: Heightened tension activates TRPV4, resulting in augmented Ca²⁺ influx.
• Transcriptional response: TRPV4-mediated Ca²⁺ influx suppresses the Hippo pathway, facilitating YAP nuclear translocation and increased expression of YAP target genes.
• P-gp upregulation: YAP activation directly drives the transcriptional upregulation of P-gp, as confirmed by mRNA and protein analysis.
• Functional chemoresistance: High viscosity–treated cells display greater resistance to doxorubicin, a hallmark substrate of P-gp, in cytotoxicity assays.

Critically, inhibition of YAP or reduction of extracellular viscosity attenuates both P-gp expression and chemoresistance, pinpointing the pathway’s specificity. These findings suggest that physical properties of the tumor microenvironment—specifically fluid viscosity—are not merely passive barriers but active modulators of drug resistance through transporter regulation. This mechanobiological insight has significant implications for drug resistance research, particularly in the design of models for transporter-mediated drug disposition and for developing strategies to overcome ABC transporter inhibition–based resistance mechanisms.

Comparison with Existing Internal Articles

This mechanistic study builds upon and extends the conceptual framework established in recent literature and internal resources. For example, "How High Viscosity Drives P-gp–Mediated Chemoresistance in Tumors" provides an overview of the role of viscosity in upregulating P-gp and reinforces the importance of physical cues in drug resistance. Meanwhile, "Navigating Chemoresistance: Tariquidar & the Tumor Microenvironment" and "Tariquidar (XR9576): Applied Workflows for Drug Resistance Research" focus on the practical deployment of selective P-gp inhibitors such as Tariquidar (XR9576) for dissecting these mechanisms in both in vitro and in vivo models. The present study provides the experimental foundation for these applied workflows by elucidating the upstream mechanotransduction processes governing P-gp expression in response to microenvironmental cues.

Limitations and Transferability

While the findings robustly link high extracellular viscosity to P-gp–mediated chemoresistance via a defined mechanosensitive pathway, several limitations should be considered. The model systems primarily involve cultured cancer cell lines under controlled viscosity conditions, which, while recapitulating key features of the tumor microenvironment, may not fully capture the complexity and heterogeneity of in vivo tumors. Additionally, the study focuses on P-gp as the primary efflux transporter, leaving open the question of whether similar pathways regulate other ABC transporters or multidrug resistance proteins under mechanical stress. The transferability of these findings to diverse tumor types and in vivo contexts will require further validation, particularly regarding clinical interventions aimed at modulating tumor viscosity or targeting downstream mechanotransduction pathways.

Research Support Resources

For researchers aiming to translate these mechanistic insights into functional assays or preclinical models, high-affinity and selective P-gp inhibitors are indispensable tools. Tariquidar (XR9576, SKU A8208) is a widely used noncompetitive inhibitor of P-glycoprotein, exhibiting nanomolar potency and specificity, which is particularly valuable for dissecting transporter-mediated drug disposition and overcoming chemoresistance in high-viscosity or transporter-upregulated models. Tariquidar is available from APExBIO and can support advanced cancer chemoresistance studies by enabling precise modulation of P-gp activity in both cell-based and animal workflows. For further protocol guidance and application strategies, researchers may consult internal resources such as "Navigating Chemoresistance: Tariquidar & the Tumor Microenvironment".